Whether you require assistance with trademark registration, trademark protection, infringement disputes, IP enforcement, patent protection, or copyright matters in India, R K Dewan & Co. offers comprehensive intellectual property legal services backed by decades of experience. Our intellectual property lawyers work with businesses, multinational corporations, and innovators to protect and enforce their IP rights in India and across international jurisdictions.
  • 1 Posts
  • 0 Photos
  • 0 Videos
  • CEO at R.K.Dewan & Co.- Intellectual Property Law Firm In India
  • Lives in Mumbai, Maharashtra, India
  • From Mumbai, Maharashtra, India
  • Male
  • Followed by 0 people
Recent Updates
  • One Drug, Many Patents: How Pharmaceutical Patent Portfolios Are Built

    One drug. Multiple patents. One powerful IP strategy. Discover how pharmaceutical companies build patent portfolios around formulations, processes, uses, and more. Our latest blog, “One Drug, Many Patents,” breaks down the strategy behind protecting valuable pharmaceutical innovations. Read now and explore how smart patent portfolio planning can strengthen protection and business value.

    https://www.rkdewan.com/blogs/pharmaceutical-patent-portfolios-one-drug-many-patents/
    One Drug, Many Patents: How Pharmaceutical Patent Portfolios Are Built One drug. Multiple patents. One powerful IP strategy. Discover how pharmaceutical companies build patent portfolios around formulations, processes, uses, and more. Our latest blog, “One Drug, Many Patents,” breaks down the strategy behind protecting valuable pharmaceutical innovations. Read now and explore how smart patent portfolio planning can strengthen protection and business value. https://www.rkdewan.com/blogs/pharmaceutical-patent-portfolios-one-drug-many-patents/
    WWW.RKDEWAN.COM
    One Drug, Many Patents: How Pharmaceutical Patent Portfolios Are Built
    Learn how pharmaceutical patent portfolios are built around one drug. Explore patent strategies, protection options, and legal considerations.
    0 Comments 0 Shares 35 Views
More Stories